Literature DB >> 8770863

Hepatic iron deprivation prevents spontaneous development of fulminant hepatitis and liver cancer in Long-Evans Cinnamon rats.

J Kato1, M Kobune, Y Kohgo, N Sugawara, H Hisai, T Nakamura, S Sakamaki, N Sawada, Y Niitsu.   

Abstract

Several clinical studies have suggested that excess hepatic iron accumulation is a progressive factor in some liver diseases including chronic viral hepatitis and hemochromatosis. However, it is not known whether iron-induced hepatotoxicity may be directly involved in hepatitis, cirrhosis, and liver cancer. The Long-Evans Cinnamon (LEC) rat, which accumulates excess copper in the liver as in patients with Wilson's disease, is of a mutant strain displaying spontaneous hemolysis, hepatitis, and liver cancer. We found previously that LEC rats harbored an additional abnormality: accumulation of as much iron as copper in the liver. In the present study, we compared the occurrence of hepatitis and liver cancer in LEC rats fed an iron-deficient diet (ID) with those in rats fed a regular diet (RD). The RD group showed rapid increments of hepatic iron concentrations as the result of hemolysis, characteristics of fulminant hepatitis showing apoptosis, and a 53% mortality rate. However, no rats in the ID group died of fulminant hepatitis. Hepatic iron, especially "free" iron concentration and the extent of hepatic fibrosis in the ID group were far less than those of the RD group. At week 65, all rats in the RD group developed liver cancer, whereas none did in the ID group. These results suggest that the accumulation of iron, possibly by virtue of synergistic radical formation with copper, plays an essential role in the development of fulminant hepatitis, hepatic fibrosis, and subsequent hepatocarcinogenesis in LEC rats.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8770863      PMCID: PMC507506          DOI: 10.1172/JCI118875

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  36 in total

Review 1.  Metallothioneins: proteins in search of function.

Authors:  M Karin
Journal:  Cell       Date:  1985-05       Impact factor: 41.582

Review 2.  Copper-overload causes cancer? The LEC rat: a model for human hepatitis, liver cancer, and much more.

Authors:  C J Powell
Journal:  Hum Exp Toxicol       Date:  1994-12       Impact factor: 2.903

3.  Wilson's disease gene is homologous to hts causing abnormal copper transport in Long-Evans cinnamon rats.

Authors:  Y Muramatsu; T Yamada; M Miura; T Sakai; Y Suzuki; T Serikawa; R E Tanzi; K Matsumoto
Journal:  Gastroenterology       Date:  1994-10       Impact factor: 22.682

4.  Long-term therapy of Wilson's disease.

Authors:  A Deiss; R E Lynch; G R Lee; G E Cartwright
Journal:  Ann Intern Med       Date:  1971-07       Impact factor: 25.391

5.  [Serum alpha-1-fetoprotein and serum lactic dehydrogenase isoenzymes in liver tumours (author's transl)].

Authors:  P Polterauer; R Rauhs; H Puxkandl
Journal:  Wien Klin Wochenschr       Date:  1981-04-03       Impact factor: 1.704

6.  New mutation causing hereditary hepatitis in the laboratory rat.

Authors:  M C Yoshida; R Masuda; M Sasaki; N Takeichi; H Kobayashi; K Dempo; M Mori
Journal:  J Hered       Date:  1987 Nov-Dec       Impact factor: 2.645

7.  THE SEPARATION OF FERRITIN AND HAEMOSIDERIN FOR STUDIES IN THE METABOLISM OF IRON.

Authors:  J W DRYSDALE; W N RAMSAY
Journal:  Biochem J       Date:  1965-04       Impact factor: 3.857

8.  Radical oxidation reactions of the purine moiety of 2'-deoxyribonucleosides and DNA by iron-containing minerals.

Authors:  M Berger; M de Hazen; A Nejjari; J Fournier; J Guignard; H Pezerat; J Cadet
Journal:  Carcinogenesis       Date:  1993-01       Impact factor: 4.944

9.  Excessive accumulation of hepatic copper in LEC rats aged 80 days without hepatitis and 130 days with hepatitis.

Authors:  N Sugawara; C Sugawara; M Sato; H Takahashi; M Mori
Journal:  Pharmacol Toxicol       Date:  1992-11

10.  Abnormal copper accumulation in non-cancerous and cancerous liver tissues of LEC rats developing hereditary hepatitis and spontaneous hepatoma.

Authors:  Y Li; Y Togashi; S Sato; T Emoto; J H Kang; N Takeichi; H Kobayashi; Y Kojima; Y Une; J Uchino
Journal:  Jpn J Cancer Res       Date:  1991-05
View more
  25 in total

1.  Redox regulation of apurinic/apyrimidinic endonuclease 1 activity in Long-Evans Cinnamon rats during spontaneous hepatitis.

Authors:  Soumendra Krishna Karmahapatra; Tapas Saha; Sanjay Adhikari; Jordan Woodrick; Rabindra Roy
Journal:  Mol Cell Biochem       Date:  2013-12-15       Impact factor: 3.396

Review 2.  Prevention of hepatocellular carcinoma: Focusing on antioxidant therapy.

Authors:  Koji Miyanishi; Toshifumi Hoki; Shingo Tanaka; Junji Kato
Journal:  World J Hepatol       Date:  2015-03-27

3.  Hepatocellular Carcinoma: An Unusual Complication of Longstanding Wilson Disease.

Authors:  Deepak Gunjan; Neeti Nadda; Saurabh Kedia; Baibaswata Nayak; Shashi B Paul; Shivanand Ramachandra Gamanagatti; Subrat K Acharya
Journal:  J Clin Exp Hepatol       Date:  2016-09-21

4.  Metallothionein-1 and metallothionein-2 gene expression and localisation of apoptotic cells in Zn-treated LEC rat liver.

Authors:  Alessandro Santon; Giacomo Carlo Sturniolo; Vincenzo Albergoni; Paola Irato
Journal:  Histochem Cell Biol       Date:  2003-04-08       Impact factor: 4.304

Review 5.  Animal models of Wilson disease.

Authors:  Emily Reed; Svetlana Lutsenko; Oliver Bandmann
Journal:  J Neurochem       Date:  2018-06-26       Impact factor: 5.372

6.  Animal models of human cerebellar ataxias: a cornerstone for the therapies of the twenty-first century.

Authors:  Mario Manto; Daniele Marmolino
Journal:  Cerebellum       Date:  2009-09       Impact factor: 3.847

7.  Sestamibi is a substrate for MDR1 and MDR2 P-glycoprotein genes.

Authors:  Brigid Joseph; Kuldeep K Bhargava; Harmeet Malhi; Michael L Schilsky; Diwakar Jain; Christopher J Palestro; Sanjeev Gupta
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-01-21       Impact factor: 9.236

8.  Hepatocellular carcinoma in a non-cirrhotic patient with Wilson's disease.

Authors:  Raphael Thattil; Jean-François Dufour
Journal:  World J Gastroenterol       Date:  2013-04-07       Impact factor: 5.742

Review 9.  Iron overload and cofactors with special reference to alcohol, hepatitis C virus infection and steatosis/insulin resistance.

Authors:  Yutaka Kohgo; Katsuya Ikuta; Takaaki Ohtake; Yoshihiro Torimoto; Junji Kato
Journal:  World J Gastroenterol       Date:  2007-09-21       Impact factor: 5.742

10.  Long-term phlebotomy with low-iron diet therapy lowers risk of development of hepatocellular carcinoma from chronic hepatitis C.

Authors:  Junji Kato; Koji Miyanishi; Masayoshi Kobune; Tokiko Nakamura; Kohichi Takada; Rishu Takimoto; Yutaka Kawano; Sho Takahashi; Minoru Takahashi; Yasushi Sato; Tetsuji Takayama; Yoshiro Niitsu
Journal:  J Gastroenterol       Date:  2007-10-15       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.